TY - JOUR T1 - Screening Instruments for Psoriatic Arthritis JF - The Journal of Rheumatology JO - J Rheumatol SP - 1623 LP - 1623 DO - 10.3899/jrheum.130474 VL - 40 IS - 9 AU - JOSEPH F. MEROLA AU - M. ELAINE HUSNI AU - ABRAR A. QURESHI Y1 - 2013/09/01 UR - http://www.jrheum.org/content/40/9/1623.abstract N2 - To the Editor:In a recent study, Walsh, et al1 sought to compare 3 published, validated screening tools for psoriatic arthritis (PsA): the Psoriasis Epidemiology Screening project (PEST), the Toronto Psoriatic Arthritis Screen (ToPAS), and the Psoriatic Arthritis Screening and Evaluation (PASE)2,3,4,5. We would like to address how PASE may not have been appropriately compared in this setting.The PASE questionnaire, developed by our group, is the only one of these 3 tools where scores have demonstrated sensitivity to change with disease activity6. PASE has similarly been shown to correlate with response to therapy7. PASE was … Address correspondence to Dr. A.A. Qureshi, Department of Dermatology, Brigham and Women’s Hospital, 221 Longwood Avenue, Boston, MA 02115, USA; E-mail: aqureshi{at}bics.bwh.harvard.edu ER -